For patients with dense breast tissue, a negative mammogram may not offer the same reassurance it does for patients with fatty breasts, since mammographic sensitivity declines as density rises.5 Yet for many of these women, that result is where screening ends. In a national analysis of negative screening mammograms among women with dense breasts, just 2.8% were followed by supplemental ultrasound within a year.2
Access appears to play a significant role. In the same analysis, the odds of receiving supplemental ultrasound were more than four times higher at facilities that offered it onsite.2 For OB/GYN practices, that points to two opportunities: a defined protocol that moves every patient with dense breast tissue toward supplemental cancer screening, and an in-office option that keeps the exam, and the revenue it generates, in the practice. SOFIA® Automated 3D Breast Ultrasound from iVu Imaging was developed to provide that in-office option.
What OB/GYN Practices Can Learn About Dense Breast Protocols from Health Systems
Health systems that have built supplemental screening into their workflows offer a useful model. One academic medical center added a breast screening pathway to its EHR as a “super order set” that included automated breast ultrasound (ABUS) for women with dense breasts. Results and an ABUS recommendation reached each woman through the patient portal or by mail, and those previously identified with dense breasts were offered same-day ABUS scheduling with their annual mammogram.3
Over five years, 40% of patients with dense breasts completed at least one ABUS exam, and by the third annual mammogram, 85% of ABUS users were scheduling both exams on the same day. Of the additional cancers ABUS detected, 89% were stage 0 or 1.3
A second health system automated the front end of the process. Its electronic workflow identified women with dense breast tissue, provided an education module and gave each the option to schedule a supplemental study or discuss it further with her provider.4
Five Steps to a Dense Breast Protocol in Your OB/GYN Practice
Both models build supplemental screening into the workflow rather than leaving it to a separate decision, and the same approach works in an OB/GYN practice, whether mammography is performed in-house or referred out.
1. Flag Density in the EMR/EHR
Breast density is now included in every mammography report,1 so the trigger for a protocol already exists. A finding of heterogeneously dense (BI-RADS C) or extremely dense (BI-RADS D) tissue should prompt a chart flag that remains active for future annual visits, with the specific category recorded.
2. Assess Risk Alongside Density
The American College of Radiology (ACR) Appropriateness Criteria tie supplemental screening recommendations to both density and risk level. Ultrasound may be appropriate for average- and intermediate-risk women with dense breasts, while breast MRI is usually appropriate for high-risk women regardless of density.6 A formal risk assessment helps route each flagged patient to the right modality.
3. Schedule at That Moment
The flag should prompt the order and the appointment together. A patient identified during an office visit can book her SOFIA exam before she leaves; when a report arrives between visits, a portal message with scheduling instructions can start the same process.
4. Tie It to the Annual Visit
Pairing the supplemental exam with the well-woman visit builds it into the patient’s routine, so rescreening doesn’t hinge on a new referral each year.
5. Define the Results Pathway
Before the first exam, the practice should establish which radiologist or teleradiology partner reads each study, who reviews the results and who follows up with the patient. Recall planning belongs here as well, since adding supplemental screening to mammography can increase recall rates.7
Keeping the Protocol In-Office with SOFIA®
A protocol is only as strong as the access behind it. SOFIA brings ABUS technology into the OB/GYN practice and is designed to run on resources the practice already has. Existing clinical staff can operate the system without adding headcount,9 and the exam requires no disposables beyond a thin layer of ultrasound lotion.8 With a 30-second scan per breast, patients can be scheduled as often as every 15 minutes.9 SOFIA doesn’t require a dedicated room; the same space can support diagnostic breast ultrasound or biopsy between screenings.8 Insurance coverage for supplemental ultrasound continues to expand as well, with more than 35 states now addressing it by law.9
The exam is designed to be comfortable and private, which matters when a protocol depends on patients returning each year. The patient lies prone on a memory-foam table and remains covered throughout.8 An ultrasound probe sealed beneath glass moves through a full 360° rotation, and a single 30-second radial sweep captures a 3D volume of the entire breast.5,8 Because each breast is captured as one volume, the radiologist can review it in multiple planes, with average interpretation times of about one minute per breast.8
In a 63-patient pilot study, medical assistants handled positioning, image acquisition and data transfer without a physician present, and total exam time was roughly half that of handheld ultrasound.5 Each study is sent as a single DICOM-compatible dataset to a local radiologist or breast teleradiologist for reading,8,9 and because ABUS is not operator dependent and is reproducible year to year, it lends itself to annual rescreening.3
Most importantly, SOFIA strengthens what the protocol is designed to do: find cancers mammography may miss. In a prospective study of 1,165 asymptomatic women with dense breasts, adding a prone SOFIA scan to mammography doubled the cancer detection rate, from four cancers to eight, and raised sensitivity from 58.8% to 93.5%.7
A dense breast protocol gives each flagged patient a defined path from density finding to supplemental screening. With SOFIA, OB/GYN practices can complete that path in the office where patients already receive their annual care.
For the full evidence base, download iVu’s white paper, Dense Breast Tissue and the Cancer Screening Gap: A Primer for Women’s Health Providers. To see how SOFIA fits into your dense breast protocol, schedule a demo.
Sources
- U.S. Food and Drug Administration. “Important Information: Final Rule to Amend the Mammography Quality Standards Act (MQSA).” https://www.fda.gov/radiation-emitting-products/mammography-quality-standards-act-mqsa-and-mqsa-program/important-information-final-rule-amend-mammography-quality-standards-act-mqsa
- Foster, V. M., et al. “Supplemental Breast Cancer Screening After Negative Mammography in US Women With Dense Breasts.” Journal of the National Cancer Institute 117, no. 6 (2025): 1271–1275. https://doi.org/10.1093/jnci/djae272.
- Paul, S., McPeek, C., et al. “Supplemental Automated Breast US Screening in Patients With Dense Breasts: 5-Year Experience From an Academic Medical Center.” Journal of Breast Imaging 7, no. 1 (2025): 35–44. https://doi.org/10.1093/jbi/wbae057.
- Supeck, D., Chavez A., et al. “Applying Implementation Science Principles to Systematize Supplemental Breast Cancer Screening for Women with Dense Breast Tissue.” Journal of the American College of Radiology 22, no. 10 (2025): 1227–31. https://doi.org/10.1016/j.jacr.2025.06.018.
- Farrokh, A., Erdönmez, H., et al. “SOFIA: A Novel Automated Breast Ultrasound System Used on Patients in the Prone Position: A Pilot Study on Lesion Detection in Comparison to Handheld Grayscale Ultrasound.” Geburtshilfe und Frauenheilkunde 78, no. 5 (2018): 499–505. https://doi.org/10.1055/a-0600-2279.
- Paulis, L., Lewin, A., et al. “ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density: 2024 Update.” Journal of the American College of Radiology 22, no. 5, supplement (2025): S405–23. https://doi.org/10.1016/j.jacr.2025.02.023.
- Gatta, G., Cappabianca, S., et al. “Second-Generation 3D Automated Breast Ultrasonography (Prone ABUS) for Dense Breast Cancer Screening Integrated to Mammography: Effectiveness, Performance and Detection Rates.” Journal of Personalized Medicine 11, no. 9 (2021): 875. https://doi.org/10.3390/jpm11090875.
- iVu Imaging. SOFIA 3D Breast Ultrasound Product Brochure.
- iVu Imaging. “OB/GYN & Primary Care.” https://ivuimaging.com/ob-gyn-and-primary-care.










.webp)
.webp)

.webp)
.webp)




.webp)











